Created with sketchtool.
Created with sketchtool.
Support for patients prescribed NERLYNX*
ACCESS AND REIMBURSEMENT
  • Benefits Verification and Prior Authorization Assistance

    This program provides comprehensive support, including benefits investigation to verify insurance coverage and assistance with prior authorization.

  • NERLYNX Quick Start

    Provides a free 3-week supply of NERLYNX to eligible patients experiencing delays in gaining access to therapy.

  • Co-Pay Assistance

    Eligible patients treated with NERLYNX may pay as little as $10 per prescription. Patients will be enrolled through their specialty pharmacy.

  • Financial Support

    For patients with financial needs, we will work to find appropriate sources for support.

ONGOING TREATMENT SUPPORT
  • NERLYNX Mentor Program

    Patient mentors provide confidential support for patients who are considering or currently taking NERLYNX.

  • Nurse Call Center

    Our staff of registered nurses by training are available to speak with patients and healthcare providers to answer questions about NERLYNX. The call center is open Monday to Friday, 9 AM to 8 PM ET, for your convenience. Call 1-855-816-5421 (when prompted, press 2). Bilingual nurses are available.

  • Product Support

    Our specialty pharmacy network will provide patients with product education and side-effect counseling to help them better understand and manage their NERLYNX therapy.

  • Text Message Support

    Patients can sign up to receive medication reminders and motivational messages to support treatment adherence.

*Puma Patient Lynx is subject to change or to be discontinued without notice. Limitations apply and certain programs are subject to eligibility criteria.

This is an informational service. Call center nurses do not offer medical advice.

Supportive Care Voucher Program
  • Up to 3 months’ free supply of antidiarrheal products

  • Available to all patients

  • Used at the dispensing pharmacy, with prescription(s) at local retail pharmacy, or through Puma Specialty Pharmacy network

For more information on the Puma Patient Lynx Support Program, call 1-855-816-5421.
How to get NERLYNX
NERLYNX is available through specific specialty pharmacies. To learn about reimbursement, download the form below.
  • AcariaHealth
    T: (800) 511-5144 F: (877) 541-1503
    Hours of operation:
    M-F, 8 am–10 pm (ET)
  • Biologics, Inc.
    T: (800) 850-4306 F: (800) 823-4506
    www.biologicsinc.com
    Hours of operation:
    M-F, 8 am–8 pm (ET)
  • Optum® Specialty Pharmacy
    T: (855) 427-4682 F: (800) 491-7997
    Hours of operation:
    Every day, 7 am–10 pm (CST)
  • Accredo® Health Group, Inc.
    T: (877) 732-3431 F: (866) 352-3973
    Hours of operation:
    M-F, 8 am–11 pm (ET)
  • CVS Caremark Specialty Pharmacy
    T: (844) 239-4761 F: (855) 296-0210
    Hours of operation:
    M-F, 8:30 am–8:30 pm (ET)
  • Onco360®
    T: (877) 662-6633 F: (877) 662-6355
    Hours of operation:
    M-F, 8 am–7 pm (ET); Sat., 9 am–2 pm (ET)

National Drug Code (NDC)

NERLYNX 40 mg film-coated tablets
Package Size: 133 tablets
NDC: 70437-240-33

National Drug Code (NDC)

NERLYNX 40 mg film-coated tablets
Package Size: 180 tablets
NDC: 70437-240-18

The NERLYNX patient co-pay card is available
Puma Biotechnology offers co-pay assistance to help qualified insured patients with the out-of-pocket costs associated with their NERLYNX prescription.
Commercially insured, eligible patients treated with NERLYNX may pay as little as $10 per prescription.* Patients will be enrolled through their specialty pharmacy. To verify your patients' eligibility or to enroll them in the co-pay card program, visit this website or call Puma Patient Lynx at 1-855-816-5421.
*Limitations apply. Patient must have commercial insurance. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Puma Biotechnology reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, call 1-855-816-5421.

INDICATIONS: NERLYNX® (neratinib) tablets, for oral use, is a kinase inhibitor indicated:

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS: None

WARNINGS AND PRECAUTIONS:

ADVERSE REACTIONS: The most common adverse reactions (reported in ≥5% of patients) were:

To report SUSPECTED ADVERSE REACTIONS, contact Puma Biotechnology, Inc. at 1-844-NERLYNX (1-844-637-5969) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS:

USE IN SPECIFIC POPULATIONS:

Please see Full Prescribing Information.